THE EFFECT OF A DUAL RECEPTOR GLUCAGON-LIKE PEPTIDE-1 AND GLUCAGON AGONIST, COTADUTIDE, ON SERUM METABOLOME IN BIOPSY PROVEN NON-CIRRHOTIC NASH WITH FIBROSIS

被引：0

作者：

Daniels, Samuel J. ^{[1
]}

Robertson, Darren ^{[1
]}

Challis, Benjamin ^{[2
]}

Sanyal, Arun J. ^{[3
]}

Shankar, Sudha S. ^{[4
]}

机构：

[1] Astrazeneca, Early Clin Dev Cardiovasc Renal & Metab, Biopharmaceut R&D, Cambridge, England

[2] Astrazeneca, Translat Sci & Expt Med, Res & Early Dev, Cardiovasc Renal & Metab,Biopharmaceut R&D, Cambridge, England

[3] Stravitz Sanyal Inst Liver Dis & Metab Hlth, VCU Sch Med, Dept Internal Med, Richmond, VA USA

[4] Astrazeneca, Early & Late Clin Dev, Cardiovasc Renal & Metab, Biopharmaceut R& D, Cambridge, England

来源：

HEPATOLOGY | 2022年 / 76卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

101

引用

页码：S92 / S92

页数：1

共 50 条

[21] Efficacy and safety of high-dose glucagon-like peptide-1, glucagon-like peptide-1/glucose-dependent insulinotropic peptide, and glucagon-like peptide-1/glucagon receptor agonists in type 2 diabetes
De Block, Christophe E. M.
Dirinck, Eveline
Verhaegen, Ann
Van Gaal, Luc F.
DIABETES OBESITY & METABOLISM, 2022, 24 (05): : 788 - 805
[22] PANCREATIC SAFETY IN STUDIES OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONIST ALBIGLUTIDE
Al-Kawas, Firas
Anderson, Michelle Ann
Enns, Robert
Wilson, Timothy H.
Johnson, Susan
Mallory, Jason M.
ENDOCRINE PRACTICE, 2019, 25 (07) : 698 - 716
[23] Glucagon-like peptide-1 receptor agonist exenatide can induce hypothermia
Shen, Yunfeng
Zhu, Hongyan
DIABETES-METABOLISM RESEARCH AND REVIEWS, 2016, 32 (SUPP 2) : 41 - 42
[24] AGONIST-INDUCED INTERNALIZATION AND RECYCLING OF THE GLUCAGON-LIKE PEPTIDE-1 RECEPTOR
WIDMANN, C
DOLCI, W
THORENS, B
DIABETES, 1994, 43 : A176 - A176
[25] Colonic Intussusception Associated With Glucagon-Like Peptide-1 Receptor Agonist Use
Gunderson, Joseph
Le Cam, Elise
Chauhan, Malini
Fallahi, Sara
Taleban, Sasha
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S2108 - S2109
[26] Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist
Buckley, Stephen T.
Baekdal, Tine A.
Vegge, Andreas
Maarbjerg, Stine J.
Pyke, Charles
Ahnfelt-Ronne, Jonas
Madsen, Kim G.
Scheele, Susanne G.
Alanentalo, Tomas
Kirk, Rikke K.
Pedersen, Betty L.
Skyggebjerg, Rikke B.
Benie, Andrew J.
Strauss, Holger M.
Wahlund, Per-Olof
Bjerregaard, Simon
Farkas, Erzsebet
Fekete, Csaba
Sondergaard, Flemming L.
Borregaard, Jeanett
Hartoft-Nielsen, Marie-Louise
Knudsen, Lotte Bjerre
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (467)
[27] Glucagon-Like Peptide-1 Receptor Agonist Liraglutide Ameliorates the Development of Periodontitis
Sawada, Noritaka
Adachi, Kei
Nakamura, Nobuhisa
Miyabe, Megumi
Ito, Mizuho
Kobayashi, Shuichiro
Miyajima, Shin-ichi
Suzuki, Yuki
Kikuchi, Takeshi
Mizutani, Makoto
Toriumi, Taku
Honda, Masaki
Mitani, Akio
Matsubara, Tatsuaki
Naruse, Keiko
JOURNAL OF DIABETES RESEARCH, 2020, 2020
[28] Impact of Glucagon-Like Peptide-1 Receptor Agonist on Gallbladder and Biliary Diseases
Alchirazi, Khaled Alsabbagh
Baliss, Michelle
El Telbany, Ahmed
Alsabbagh, Muaz
Alsakarneh, Saqr
Kiwan, Wissam
Bilal, Mohammad
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S132 - S132
[29] Rational Design of a Humanized Glucagon-Like Peptide-1 Receptor Agonist Antibody
Zhang, Yong
Zou, Huafei
Wang, Ying
Caballero, Dawna
Gonzalez, Jose
Chao, Elizabeth
Welzel, Gus
Shen, Weijun
Wang, Danling
Schultz, Peter G.
Wang, Feng
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2015, 54 (07) : 2126 - 2130
[30] PROXYMO DEMONSTRATES SAFETY AND EFFICACY OF COTADUTIDE, A NOVEL INCRETIN CO-AGONIST IN BIOPSY-PROVEN NON-CIRRHOTIC NASH WITH FIBROSIS
Robertson, Darren
Challis, Benjamin
Daniels, Samuel J.
Sarv, Janeli
Sanchez, Jose
Schumi, Jennifer
Manzur, Antonio
Gan, Li-Ming
Jermutus, Lutz
Sanyal, Arun J.
Shankar, Sudha S.
HEPATOLOGY, 2021, 74 (06) : 1386A - 1386A

← 1 2 3 4 5 →